Stock ALGETA ALGETA ASA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Algeta ASA Stock

Equities

ALGETA

NO0010239437

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Chart Algeta ASA

Dynamic Chart

Latest news about Algeta ASA

Actavis : Factbox - M&A frenzy transforming global pharma RE
Actavis : M&A frenzy in healthcare sector RE
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo RE
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid RE
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta RE
OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta RE
Bayer AG : Bayer says does not want to provide details on Algeta offer RE
More news

Press releases Algeta ASA

Algeta ASA : Algeta to host Capital Markets Days PU
Algeta ASA : CORRECTION: Algeta ASA : Algeta Results for the Third Quarter 2013 PU
Algeta ASA : Algeta's Financial Calendar 2014 PU
Algeta ASA : Algeta to Participate in Upcoming Investor Conferences PU
Algeta ASA : Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call PU
More press releases

News in other languages on Algeta ASA

Algeta : décolle de 30% à Oslo, offre de Bayer.
More news

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.57% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.73% 106B
ARGENX SE Stock argenx SE
-3.17% 21.96B
BIONTECH SE Stock BioNTech SE
-14.26% 21.87B
GENMAB A/S Stock Genmab A/S
-5.29% 19.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-3.48% 18.08B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 17.71B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.45% 14.32B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.21% 12.42B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ALGETA Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW